Efficacy of repetitive transcranial magnetic stimulation for treatment-resistant psychiatry disorders

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045279

Enrollment

Unknown

Registered

2021-04-10

Start date

2019-11-22

Completion date

Unknown

Last updated

2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

treatment-resistant psychiatry disorders

Interventions

experimental group:repetitive transcranial magnetic stimulation

Eligibility

Sex/Gender

All

Age

12 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 12-45 years; 2. Patients who meet the diagnostic criteria of DSM-IV for treatment-resistant depression and schizophrenia; 3. Fully understand the purpose, method, process, possible discomfort, and risk of the experiment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Concomitant major medical disorders; 2. Neurological disorders or history of head trauma with loss of consciousness >= 5 min; 3. Suicidal ideation or suicidal attempt; 4. IQ < 70; 5. Pregnancy; 6. Substance/alcohol abuse or dependence; 7. MRI contraindications.

Design outcomes

Primary

Measure	Time frame
Hamilton Depression Scale, HAMD;MRI;Brief Psychiatric Rating Scale, BPRS;	—

Secondary

Measure	Time frame
Hamilton Anxiety Scale, HAMA ;Young Mania Rating Scale, YMRS;Patien Health Questionnare, PHQ-9;Generalized Anxiexy Disorde-7, GAD-7;MATRICS Consensus Cognitive Battery, MCCB;Wsiconsin card sorting test, WCST);	—

Countries

China

Contacts

Public ContactFei Wang

The First Affiliated Hospital of China Medical University

feiwangster@gmail.com+86 15840220877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026